(Q32026613)

5 July 2017

0 references

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome (English)

1 reference

5 July 2017

1 reference

irritable bowel syndrome

1 reference

1

Poynard T

1 reference

5 July 2017

Regimbeau C

2

1 reference

PubMed ID

11207510

5 July 2017

Benhamou Y

series ordinal

3

1 reference

PubMed ID

11207510

5 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Alimentary Pharmacology & Therapeutics

5 July 2017

1 reference

5 July 2017

15

1 reference

5 July 2017

3

1 reference

5 July 2017

355-361

1 reference

Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients

5 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Meta-analyses of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Review article: critical review of meta-analyses of randomized clinical trials in hepatogastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

A Trial of Trimebutine in Spastic Colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

A three-part controlled study of trimebutine in the treatment of irritable colon syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Review article: clinical evidence to support current therapies of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

A Clinical Trial of Trimebutine (Mebutin) in Spastic Colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00937.X

10.1046/J.1365-2036.2001.00937.X

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference

PubMed ID

11207510